Daniel J. Abrams, M.D., CEO

Dr. Abrams is a cofounder of Cerebral Therapeutics and serves as its CEO.  Prior to founding Cerebral Therapeutics, Dr. Abrams founded Sierra Neuropharmaceuticals, Inc., raising $21.5 million in Series A venture capital and put together a world class team of advisers, physician leaders and executives to form its board of directors.  Dr. Abrams was active with Sierra Neuropharmaceuticals, Inc. until July of 2009.  Dr. Abrams practiced as a neurosurgeon and served as head of the Department of Neurosurgery at St. Joseph’s Hospital in Denver.  Dr. Abrams’ practical experience with implantable pumps and medications in neurology and psychiatry, and his experience with interdisciplinary medical teams and research groups, make him uniquely qualified to lead Cerebral Therapeutics with its focus on development of brain drug delivery.


Ashwini Sharan, M.D., Senior Medical and Scientific Advisor

Professor Sharan is the Surgical Director of the Epilepsy Center and the Residency Program Directory at Jefferson University. In addition, Dr. Sharan is the President of the North American Neuromodulation Society and the Congress of Neurological Surgeons.  Dr. Sharan is one of the leaders who developed the field of Neuromodulation as a leading area in Neurological Surgery.  Dr. Sharan is the author of numerous papers, holds multiple patents and serves as an international physician leader in new therapy development, education, and patient advocacy.



David Jenkins, Board Member

David Jenkins has spent more than 30 years as a business entrepreneur. He has had several successful experiences starting companies and developing them into market leaders.

Steve Adler

Steve Adler, Company Adviser

Steve Adler has spent 25 years as a business entrepreneur in the Cardiac and Functional Central Nervous System market responsible for developing and launching more than 20 different medical devices.  Steve was the CEO of Flowonix, an implantable infusion system company,  


Robert Fisher, MD Senior Scientific and Medical Adviser

Dr. Fisher is Maslah Saul MD Professor and Director of the Stanford Epilepsy Center. He had research awards from the Klingenstein Foundation, EF, CURE and NIH. He has published 160 peer-reviewed articles and 4 books. He was named 1996-2016 in Best Doctors in America. He received the Ambassador Award from the International League Against Epilepsy, the 2005 AES Service Award and the 2006 Annual Clinical Research Award. Dr. Fisher is Past-President of the American Epilepsy Society, and has served on the Board of the ILAE and as Editor-in-Chief of the Journal, Epilepsia. He is past Editor-in-Chief of the website epilepsy.com.